|

Mid-Afternoon Market Update: Crude Oil Down 1.5%; C&J Energy Services Shares Spike Higher

Toward the end of trading Monday, the Dow traded up 0.20% to 26,141.97 while the NASDAQ rose 0.81% to 7,859.85. The S&P also rose, gaining 0.25% to 2,894.11.

Leading and Lagging Sectors

Real estate shares rose 1.1% on Monday. Meanwhile, top gainers in the sector includedInnovative Industrial Properties, Inc. IIPR 8.66%, up 9%, and Office Properties Income Trust OPI 8.09%, up 8%.

In trading on Monday, materials shares fell by 0.9%.

Top Headline

Array BioPharma ARRY 56.47% announced it will be acquired by Pfizer PFE 0.14% for $48 per share in cash for a total value of around $11.4 billion.

Array’s portfolio of medicines includes cancer treatment for metastatic melanoma. In the U.S., colorectal cancer is the third most common type of cancer in men and women and an estimated 140,250 patients were diagnosed with cancer of the colon or rectum in 2018.

Equities Trading UP

Sotheby's BID 58.71% shares shot up 59% to $56.15 after the company announced it will be acquired by BidFair for $57 per share in cash. The offer price represents a premium of 61% to Sotheby's closing price on Friday.

Shares of Array BioPharma Inc. ARRY 56.47% got a boost, shooting up 57% to $46.31 afterPfizer Inc. PFE 0.14% announced plans to acquire Array BioPharma for $48 per share in cash.

C&J Energy Services Inc CJ 25.22% shares were also up, gaining 25% to $13.35 following merger newsKeane Group Inc FRAC 12.09% announced plans to buy C&J Energy for $745.7 million in an all-stock transaction.

Equities Trading DOWN

VBI Vaccines Inc. VBIV 66.66% shares tumbled 67% to $0.6302 following the release of data from a late-stage study of its hepatitis B virus vaccine candidate. The thinly traded micro-cap biotech said the Phase 3 study dubbed PROTECT showed that both the co-primary endpoints were met but not the secondary endpoint. The trialevaluated the efficacy and safety of a 10-microgram dose of Sci-B-Vac, its trivalent HBV, compared with a 20-microgram dose of comparator vaccine Engerix-B. Engerix B, marketed by GlaxoSmithKline, is the current standard of care.

Shares of Flex Pharma, Inc. FLKS 19.23% were down 20% to $0.5121 after the company announced more shareholder votes are required to complete its merger with Salarius Pharma despite “overwhelming support.”

Ampio Pharmaceuticals, Inc. AMPE 28.99% was down, falling 30% to $0.4893 after the company priced a 25.32 million share common stock offering at $0.40 per share.

Commodities

In commodity news, oil traded down 1.5% to $51.71, while gold traded down 0.2% to $1,342.40.

Silver traded up 0.1% Monday to $14.81, while copper rose 0.8% to $2.6505.

Euro zone

European shares closed mostly lower today. The eurozone’s STOXX 600 fell 0.09%, the Spanish Ibex Index fell 0.68%, while Italy’s FTSE MIB Index gained 0.07%. Meanwhile, the German DAX slipped 0.09%, and the French CAC 40 rose 0.43% while UK shares rose 0.16%.

Economics

The Empire State manufacturing index declined 26.4 points to a reading of -8.6 in June. However, economists were projecting a reading of 11.

The NAHB housing market index fell to 64 for June, versus prior reading of 66. However, economists projected a reading of 67.

The Treasury International Capital report for April is schedule for release at 4:00 p.m. ET.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

EUR/USD shifts its attention to 1.1900 and above

EUR/USD has shaken off Tuesday’s dip, pushing back beyond the 1.1800 mark amid decent gains as  Wednesday’s session draws to a close. The rebound is largely driven by a modest pullback in the US Dollar, as markets digest the aftermath of President Trump’s SOTU speech and continue to monitor trade-related headlines and signals from the White House.
 

GBP/USD challenges multi-day highs near 1.3530

GBP/USD leaves behind the previous day’s decline and regains fresh upside traction on Wednesday, surpassing the 1.3500 barrier in a context of a modest decline in the Greenback and a generalised improved mood in the risk-linked space. Meanwhile, the US tariff narrative continues to dictate the mood among market participants after Presidet Trump’s SOTU speech failed to surprise markets.

Gold remains bid and close to $5,200

Gold buyers are returning to the fold on Wednesday, targeting the $5,200 area and possibly beyond, after Tuesday’s corrective dip from monthly highs. The rebound in the precious metal comes as the US Dollar loses traction, with Trump’s SOTU speech offering little fresh direction and AI-related nerves continuing to ease.

UK financial watchdog advances stablecoin oversight as four firms pilot issuance

The Financial Conduct Authority (FCA) in the United Kingdom (UK) is advancing toward the final stablecoin regulatory framework with a pilot program involving four companies, including Monee, Financial Technologies ReStabilise, Revolut and VVTX.

Nvidia earnings to influence AI trade and broader market sentiment

For the last three years, Nvidia has been the engine of the AI boom, and now Wall Street is watching to see whether that momentum can keep going. High-growth stocks have been struggling to maintain their bullish trend in 2026.

Cosmos Hub Price Forecast: ATOM rebounds slightly, bearish outlook remains intact

Cosmos Hub (ATOM) price rebounds, trading above $2.05 at the time of writing on Wednesday, after undergoing a sharp correction since last week. Weakening on-chain and derivatives data support a bearish outlook, while technical analysis remains unfavorable.